We were able to demonstrate that the levels of urinary ALCAM were elevated in active LN patients as compared to active SLE without renal involvement, inactive LN, inactive SLE patients without renal involvement, and healthy controls. This evidence concerns the gene ALCAM and lobular neoplasia.